Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized StudyDaniel R. Gomez, John V. Heymach, Chad Tang et al.|Journal of Clinical Oncology|2019Cited by 1.3k
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 studyDaniel R. Gomez, John V. Heymach, George R. Blumenschein et al.|The Lancet Oncology|2016Cited by 1.1k
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLCMarcelo V. Negrão, Sandip Pravin Patel, Giannis Mountzios et al.|Cancer Discovery|2023Cited by 181
Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discoveryShin‐Heng Chiou, Mark M. Davis, Diane Tseng et al.|Immunity|2021Cited by 134
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancerMing Chen, Jianjun Zhang|Nature Communications|2021Cited by 50